Cash · 2011–2025
Karyopharm Therapeutics cash
$60.5M−3.1% · FY2025
Karyopharm Therapeutics (KPTI) reported $60.5M in cash for fiscal 2025, −3.1% year on year.
| Fiscal year | Cash | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $60.5M | −3.1% | Open → |
| FY20242024-12-31 | $62.5M | +19.6% | Open → |
| FY20232023-12-31 | $52.2M | −61.4% | Open → |
| FY20222022-12-31 | $135M | −29.0% | Open → |
| FY20212021-12-31 | $190M | +121.7% | Open → |
| FY20202020-12-31 | $85.9M | −33.3% | Open → |
| FY20192019-12-31 | $129M | +9.2% | Open → |
| FY20182018-12-31 | $118M | +71.1% | Open → |
| FY20172017-12-31 | $69.0M | +38.9% | Open → |
| FY20162016-12-31 | $49.7M | −14.9% | Open → |
| FY20152015-12-31 | $58.4M | −61.3% | Open → |
| FY20142014-12-31 | $151M | −3.4% | Open → |
| FY20132013-12-31 | $156M | +39,791.0% | Open → |
| FY20122012-12-31 | $391,000 | −94.0% | Open → |
| FY20112011-12-31 | $6.5M | — | Open → |
Cash — Cash and cash equivalents is money available immediately at the balance-sheet date. It excludes short-term investments, which many large companies hold far more of.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +17.3%
Cash at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Karyopharm Therapeutics cash |url=https://companiesranked.com/en/company/karyopharm-therapeutics/cash-on-hand |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Karyopharm Therapeutics cash. CompaniesRanked. https://companiesranked.com/en/company/karyopharm-therapeutics/cash-on-handBibTeX
@misc{companiesranked-en-company-karyopharm-therapeutics-cash-on-hand-2026,
author = {{CompaniesRanked}},
title = {{Karyopharm Therapeutics cash}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/karyopharm-therapeutics/cash-on-hand}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001193125-26-347906 · August 13, 2026
{{cite web |title=Karyopharm Therapeutics cash — 10-Q (0001193125-26-347906) |url=https://www.sec.gov/Archives/edgar/data/1503802/000119312526347906/kpti-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-13}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.